Canada markets closed

Nanobiotix S.A. (NANO.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
6.37+0.16 (+2.58%)
At close: 05:35PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 300.10M
Enterprise Value 275.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.83
Price/Book (mrq)61.99
Enterprise Value/Revenue 8.73k
Enterprise Value/EBITDA -2.26

Trading Information

Stock Price History

Beta (5Y Monthly) 1.26
52-Week Change 343.25%
S&P500 52-Week Change 326.27%
52 Week High 310.40
52 Week Low 34.23
50-Day Moving Average 35.70
200-Day Moving Average 36.55

Share Statistics

Avg Vol (3 month) 343.7k
Avg Vol (10 day) 343.03k
Shares Outstanding 547.11M
Implied Shares Outstanding 647.38M
Float 827.78M
% Held by Insiders 114.28%
% Held by Institutions 116.80%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -109.64%
Operating Margin (ttm)3.46%

Management Effectiveness

Return on Assets (ttm)-19.72%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)36.21M
Revenue Per Share (ttm)0.98
Quarterly Revenue Growth (yoy)854.90%
Gross Profit (ttm)N/A
EBITDA -23.69M
Net Income Avi to Common (ttm)-39.7M
Diluted EPS (ttm)-1.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)75.28M
Total Cash Per Share (mrq)1.6
Total Debt (mrq)50.56M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.75
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-12.48M
Levered Free Cash Flow (ttm)-5.27M